Holen Sie sich die Stockscreener-App
26.38
0.42%
-0.11
Handel nachbörslich:
26.45
0.07
+0.27%
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
FY2024 EPS Estimates for Scholar Rock Cut by HC Wainwright - Defense World
What is Wedbush’s Forecast for Scholar Rock FY2024 Earnings? - Defense World
Redmile Group, LLC Expands Stake in Scholar Rock Holding Corp - GuruFocus.com
OrbiMed Advisors LLC Adjusts Stake in Scholar Rock Holding Corp - GuruFocus.com
FY2024 Earnings Forecast for Scholar Rock Issued By Wedbush - MarketBeat
Analysts Set Expectations for Scholar Rock FY2024 Earnings - MarketBeat
FY2028 Earnings Forecast for Scholar Rock Issued By Wedbush - MarketBeat
HC Wainwright Comments on Scholar Rock Q3 Earnings - MarketBeat
Scholar Rock chief medical officer sells $63k in stock By Investing.com - Investing.com Australia
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
Scholar Rock chief medical officer sells $63k in stock - Investing.com
Scholar Rock Holding Corporation (NASDAQ:SRRK) Q3 2024 Earnings Call Transcript - Insider Monkey
Creative Planning Invests $115,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and Promising Study Results - GuruFocus.com
Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ... - Yahoo Finance
FMR LLC Bolsters Position in Scholar Rock Holding Corp - GuruFocus.com
Scholar Rock Holding Corp Reports Q3 2024 Net Loss of $64.5 Mill - GuruFocus.com
Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress - BioSpace
Scholar Rock Holding Corp (SRRK) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Scholar Rock (NASDAQ:SRRK) Earns “Outperform” Rating from Wedbush - Defense World
Scholar Rock (SRRK) Scheduled to Post Earnings on Tuesday - MarketBeat
Vanguard Group Inc's Strategic Acquisition in Scholar Rock Holdi - GuruFocus.com
Scholar Rock's (SRRK) Outperform Rating Reiterated at Wedbush - MarketBeat
Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin - BioSpace
Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024 - BioSpace
abrdn plc Raises Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock to Participate in Upcoming Investor Conferences - BioSpace
Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting - sharewise
Stocks to Watch: Bitcoin, technology companies, medical research lead Nasdaq (Oct. 21-25) - The News Record
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by E. Ohman J or Asset Management AB - MarketBeat
Dow Jones, S&P 500 fall amid rising oil prices; Scholar Rock jumps 300%, Apple and insurance stocks dip - MSN
Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
Scholar Rock Closes of Full Exercise of Option to Purchase Additional Shares in Public Offering - citybiz
Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering - Business Wire
Should You Buy Scholar Rock Holding Corporation (SRRK) After Golden Cross? - Yahoo Finance
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan
Scholar Rock Holding Co. (NASDAQ:SRRK) Shares Bought by Exchange Traded Concepts LLC - MarketBeat
AQR Capital Management LLC Has $331,000 Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock’s stock soars more than 315% on positive trial of treatment for spinal muscular atrophy - MSN
AQR Capital Management LLC Boosts Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) PT Raised to $42.00 at Piper Sandler - Defense World
Analysts Set Scholar Rock Holding Co. (NASDAQ:SRRK) PT at $28.25 - Defense World
Scholar Rock Holding Corp (SRRK) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Keros Therapeutics Appoints Yung H. Chyung, M.D., as Chief Medical Officer - GlobeNewswire
Scholar Rock stock could benefit from Biohaven's Ph3 results, Truist raises potential rally outlook - Investing.com UK
H.C. Wainwright reiterates Scholar Rock Holding Corp (SRRK) rating to a Buy - Knox Daily
Piper Sandler raises Scholar Rock stock target By Investing.com - Investing.com UK
Piper Sandler Boosts Scholar Rock (NASDAQ:SRRK) Price Target to $42.00 - MarketBeat
SRRK’s Market Whiplash: 51.70% YTD Rise, 232.79% Rise in 30 Days - The InvestChronicle
Ratios Reveal: Breaking Down Scholar Rock Holding Corp (SRRK)’s Financial Health - The Dwinnex
Scholar Rock (NASDAQ:SRRK) Trading 9.5% Higher Following Analyst Upgrade - Defense World
Scholar Rock (NASDAQ:SRRK) Trading Up 9.5% Following Analyst Upgrade - MarketBeat
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):